LOGAN SCOTT MURRAY

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant TAMPA, FL NPI 1669037396

General Payments — all program years on this page

$6,488.63

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 52
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $3,357.09 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Honoraria $1,612.502
Travel and Lodging $946.982
Food and Beverage $557.2512
Education $240.363

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $240.862
2023 $2,890.6831
2024 $3,357.0919

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087111044 Novartis Pharmaceuticals Corporation $22.82 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089460605 Daiichi Sankyo Inc. $18.26 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089460609 Daiichi Sankyo Inc. $29.64 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089460613 Daiichi Sankyo Inc. $23.32 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089460623 Daiichi Sankyo Inc. $19.32 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089460627 Daiichi Sankyo Inc. $18.18 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117335248 Amgen Inc. $118.42 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135741484 Lilly USA, LLC $106.57 09/18/2024 Education Undisputed 01/23/2026 View at CMS
1135753533 Lilly USA, LLC $4.00 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135821895 Lilly USA, LLC $83.80 09/18/2024 Education Undisputed 01/23/2026 View at CMS
1141207069 Incyte Corporation $49.99 12/03/2024 Education Undisputed 01/23/2026 View at CMS
1147454087 Blueprint Medicines Corporation $30.84 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147454115 Blueprint Medicines Corporation $101.08 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147454139 Blueprint Medicines Corporation $40.87 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147454149 Blueprint Medicines Corporation $525.00 01/03/2024 Honoraria Undisputed 01/23/2026 View at CMS
1147454185 Blueprint Medicines Corporation $578.88 11/05/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1147454187 Blueprint Medicines Corporation $368.10 11/05/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1147454189 Blueprint Medicines Corporation $1,087.50 11/05/2024 Honoraria Undisputed 01/23/2026 View at CMS
1150264359 Adaptive Biotechnologies Corporation $130.50 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.